prof. Petra Schelstraete

Journal Article
A1
open access

Case report : integrated genomic and immunological assays identify non-coding CFB variants in pneumococcal meningoencephalitis

Jana Barbieur (UGent) , Evelien D'Haenens, Tamara Jarayseh (UGent) , Levi Hoste (UGent) , J. Smet, Stefanie Lambrecht, Eva Schiettecatte (UGent) , Petra Schelstraete (UGent) , Marieke De Bruyne (UGent) , Filomeen Haerynck (UGent) , et al.

(2026) FRONTIERS IN IMMUNOLOGY. 17.

Add to list

Bedside model-informed precision dosing of vancomycin in severely ill neonates and children in Belgium (the BENEFICIAL trial) : a multicentre, randomised controlled trial

Pieter De Cock (UGent) , Roos Colman (UGent) , Anne Smits, Fiammetta Piersigilli, Marleen Renard, An Van Damme, Alexander Clarysse, Evelyn Dhont (UGent) , Sophie Vanhaesebrouck (UGent) , Victoria Bordon, et al.

(2026) LANCET CHILD & ADOLESCENT HEALTH. 10(6). p.406-417

Add to list

Developing tailored dosing recommendations for ciprofloxacin in critically ill children using a population approach based on total and unbound concentrations

Pieter-Jan De Sutter (UGent) , Evelyn Dhont (UGent) , Daphne Vens, Peter De Paepe (UGent) , Jef Willems (UGent) , Petra Schelstraete (UGent) , Jan Van Bocxlaer (UGent) , An Vermeulen (UGent) and Pieter De Cock (UGent)

(2026) CLINICAL MICROBIOLOGY AND INFECTION. 32(2). p.266-271

Add to list

Journal Article
A1
open access

Be-SNAP : the Belgian Sepsis National Action Plan

Annelies Mondelaers, Febe Van de Voorde, Harlinde Peperstraete (UGent) , Ken Dewitte, Jan De Waele (UGent) , Ilse Malfait, Patrick Van de Voorde (UGent) , Erika Vlieghe, Pieter Depuydt (UGent) , Peter Pype (UGent) , et al.

(2025) FRONTIERS IN PUBLIC HEALTH. 13.

Add to list

Shifts in systemic inflammatory profiles on elexacaftor/tezacaftor/ivacaftor predict clinical outcomes in cystic fibrosis

Leander Jonckheere (UGent) , Lieve Vande Sande, Iris Janssens (UGent) , Yannick Vande Weygaerde (UGent) , Stephanie Van Biervliet (UGent) , Heidi Schaballie (UGent) , Petra Schelstraete (UGent) , Tania Maes (UGent) , Cedric Bosteels (UGent) and Eva Van Braeckel (UGent)

(2025) JOURNAL OF CYSTIC FIBROSIS. In Journal of Cystic Fibrosis 24(Supplement 1). p.S20-S20

Add to list

Developing evidence-based dosing recommendations for intravenous ciprofloxacin in critically ill children: a population pharmacokinetic study using total and unbound concentrations

Pieter-Jan De Sutter (UGent) , Evelyn Dhont (UGent) , Daphné Vens, Peter De Paepe (UGent) , Jef Willems (UGent) , Petra Schelstraete (UGent) , Jan Van Bocxlaer (UGent) , An Vermeulen (UGent) and Pieter De Cock (UGent)

(2025) European Society for Developmental, Perinatal and Paediatric Pharmacology (ESDPPP), 21st Congress, Abstracts. In Pediatric Drugs 27(4). p.518-519

Add to list

Journal Article
A1
open access

Impact of reporting rapid susceptibility results in Gram negative bloodstream infections : a real world prospective study

Anne-Sophie Messiaen (UGent) , Stien Vandendriessche (UGent) , Emilie De Muynck, Gregory Strubbe (UGent) , Liesbet De Bus (UGent) , Petra Schelstraete (UGent) , Kristen Decommer, Sanne De Smet (UGent) , Alexander Soetens, Leslie Naesens (UGent) , et al.

(2025) EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 44(4). p.847-853

Add to list

Journal Article
A1
open access

The use of information technology to improve interdisciplinary communication during infectious diseases ward rounds on the paediatric intensive care unit

Jef Willems (UGent) , Adeline Heyndrickx, Petra Schelstraete (UGent) , Bram Gadeyne (UGent) , Pieter De Cock (UGent) , Stien Vandendriessche (UGent) and Pieter Depuydt (UGent)

(2024) SCIENTIFIC REPORTS. 14(1).

Add to list

‘Let’s START TO TDM’ : advancing a pharmacy-led therapeutic drug monitoring advisory service within an antimicrobial stewardship program

Pieter De Cock (UGent) , Elise Sevens, Sabine Deryckere (UGent) , Barbara Claus (UGent) , Franky Buyle (UGent) , Katleen Van Butsele (UGent) , Petra Schelstraete (UGent) , Diana Huis in 't Veld (UGent) and Annemie Somers (UGent)

(2024) Dag Van De Ziekenhuisapotheker 2024, Abstracts.

Add to list

Evaluation and expansion of a pharmacy-led therapeutic drug monitoring advisory service as part of an antimicrobial stewardship programme

Pieter De Cock (UGent) , Sabine Deryckere (UGent) , Barbara Claus (UGent) , Franky Buyle (UGent) , Katleen Van Butsele (UGent) , Petra Schelstraete (UGent) , Diana Huis in 't Veld (UGent) and Annemie Somers (UGent)

(2024) 34th Congress of the European Society of Clinical Microbiology and Infectious Diseases, ESCMID Global 2024, Abstracts.

Academic Bibliography

prof. Petra Schelstraete

Case report : integrated genomic and immunological assays identify non-coding CFB variants in pneumococcal meningoencephalitis

Bedside model-informed precision dosing of vancomycin in severely ill neonates and children in Belgium (the BENEFICIAL trial) : a multicentre, randomised controlled trial

Developing tailored dosing recommendations for ciprofloxacin in critically ill children using a population approach based on total and unbound concentrations

Be-SNAP : the Belgian Sepsis National Action Plan

Shifts in systemic inflammatory profiles on elexacaftor/tezacaftor/ivacaftor predict clinical outcomes in cystic fibrosis

Developing evidence-based dosing recommendations for intravenous ciprofloxacin in critically ill children: a population pharmacokinetic study using total and unbound concentrations

Impact of reporting rapid susceptibility results in Gram negative bloodstream infections : a real world prospective study

The use of information technology to improve interdisciplinary communication during infectious diseases ward rounds on the paediatric intensive care unit

‘Let’s START TO TDM’ : advancing a pharmacy-led therapeutic drug monitoring advisory service within an antimicrobial stewardship program

Evaluation and expansion of a pharmacy-led therapeutic drug monitoring advisory service as part of an antimicrobial stewardship programme

Contents

Support

Contact